66 related articles for article (PubMed ID: 20981458)
1. Synergic effect of α-tocopherol and naringenin in transglutaminase-induced differentiation of human prostate cancer cells.
Torricelli P; Ricci P; Provenzano B; Lentini A; Tabolacci C
Amino Acids; 2011 Nov; 41(5):1207-14. PubMed ID: 20981458
[TBL] [Abstract][Full Text] [Related]
2. γ-Tocopherol inhibits human prostate cancer cell proliferation by up-regulation of transglutaminase 2 and down-regulation of cyclins.
Torricelli P; Caraglia M; Abbruzzese A; Beninati S
Amino Acids; 2013 Jan; 44(1):45-51. PubMed ID: 22460364
[TBL] [Abstract][Full Text] [Related]
3. The effect of alpha- and gamma-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation.
Galli F; Stabile AM; Betti M; Conte C; Pistilli A; Rende M; Floridi A; Azzi A
Arch Biochem Biophys; 2004 Mar; 423(1):97-102. PubMed ID: 14871472
[TBL] [Abstract][Full Text] [Related]
4. Reduction of oxidative stress and ornithine decarboxylase expression in a human prostate cancer cell line PC-3 by a combined treatment with α-tocopherol and naringenin.
Torricelli P; Elia AC; Magara G; Feriotto G; Forni C; Borromeo I; De Martino A; Tabolacci C; Mischiati C; Beninati S
Amino Acids; 2021 Jan; 53(1):63-72. PubMed ID: 33398525
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer: chemoprevention update 2005.
Fleshner N; Al Azab R
Can J Urol; 2005 Jun; 12 Suppl 2():2-4. PubMed ID: 16018824
[TBL] [Abstract][Full Text] [Related]
7. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
[TBL] [Abstract][Full Text] [Related]
8. Vitamin E, alpha- and gamma-tocopherol, and prostate cancer.
Moyad MA; Brumfield SK; Pienta KJ
Semin Urol Oncol; 1999 May; 17(2):85-90. PubMed ID: 10332921
[TBL] [Abstract][Full Text] [Related]
9. Differential retention of alpha-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells.
Ni J; Pang ST; Yeh S
Prostate; 2007 Apr; 67(5):463-71. PubMed ID: 17252538
[TBL] [Abstract][Full Text] [Related]
10. Vitamins and prostate cancer risk.
Donkena KV; Karnes RJ; Young CY
Molecules; 2010 Mar; 15(3):1762-83. PubMed ID: 20336012
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of anticancer actions of natural and synthetic vitamin E forms.
Yu W; Jia L; Wang P; Lawson KA; Simmons-Menchaca M; Park SK; Sun L; Sanders BG; Kline K
Mol Nutr Food Res; 2008 Apr; 52(4):447-56. PubMed ID: 18381678
[TBL] [Abstract][Full Text] [Related]
12. The roles of alpha-vitamin E and its analogues in prostate cancer.
Ni J; Yeh S
Vitam Horm; 2007; 76():493-518. PubMed ID: 17628187
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro effect of baicalein on human prostate cancer cells.
Miocinovic R; McCabe NP; Keck RW; Jankun J; Hampton JA; Selman SH
Int J Oncol; 2005 Jan; 26(1):241-6. PubMed ID: 15586246
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S
Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112
[TBL] [Abstract][Full Text] [Related]
15. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
Li L; Zhu Z; Joshi B; Porter AT; Tang DG
Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
[TBL] [Abstract][Full Text] [Related]
16. The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study.
Hartman TJ; Albanes D; Pietinen P; Hartman AM; Rautalahti M; Tangrea JA; Taylor PR
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):335-40. PubMed ID: 9568790
[TBL] [Abstract][Full Text] [Related]
17. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention.
Crispen PL; Uzzo RG; Golovine K; Makhov P; Pollack A; Horwitz EM; Greenberg RE; Kolenko VM
Prostate; 2007 May; 67(6):582-90. PubMed ID: 17262802
[TBL] [Abstract][Full Text] [Related]
19. The G gamma / T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089.
Perez-Stable CM; Schwartz GG; Farinas A; Finegold M; Binderup L; Howard GA; Roos BA
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):555-63. PubMed ID: 12050097
[TBL] [Abstract][Full Text] [Related]
20. RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects.
Yin Y; Ni J; Chen M; Guo Y; Yeh S
Clin Cancer Res; 2009 Jan; 15(1):190-200. PubMed ID: 19118046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
